Liver Cancer
Copyright ©The Author(s) 2003.
World J Gastroenterol. Feb 15, 2003; 9(2): 276-280
Published online Feb 15, 2003. doi: 10.3748/wjg.v9.i2.276
Table 1 Incidence of Different GGTmRNA types in Livers of Each Group
GroupNo. of SamplesType of GGTmRNA
A (%)B (%)C (%)
1.Normal1212 (100%)03 (25.00%)
2.Acute hepatitis1514 (93.33%)1 (6.67%)2 (13.33%)
3.Chronic hepatitis1816 (88.89%)3 (16.67%)4 (22.22%)
4.Cirrosis119 (81.82%)3 (27.27%)2 (18.18%)
5.Alcoholic hepatopathy1312 (92.31%)1 (7.69%)3 (23.08%)
6.Hepatic benign tumor1010 (100%)01 (10.00%)
7.Secondary carcinoma of liver1311 (84.62%)03 (23.08%)
8.HCC32
Cancerous tissues3215 (46.88%)a28 (87.5%)a2 (6.25%)
Adjacent Paracancerous tissues2118 (85.71%)17 (80.95%)a3 (14.29%)
Distal Cancerous tissues2119 (90.48%)16 (76.19%)a2 (9.52%)
Noncancerous tissues119 (81.82%)8 (72.73%)a1 (9.09%)
Table 2 GGTmRNA and the size of HCC
casesCancerous tissues type ACancerous tissues type BNon cancerous tissues type BPeripheral blood type B
Small sized HCC85 (62.50%)6 (75.00%)5 (62.50%)2 (25.00%)
Large sized HCC167 (43.75%)15 (93.75%)14 (87.50%)6 (37.50%)
Enormous sized HCC83 (37.50%)7 (87.50%)7 (87.50%)4 (50.00%)